Send Inquiry

Request To Call Back

DECZUBA DECITABINE INJECTION

Get a Price/Quote

MOQ : 1 Bottle

DECZUBA DECITABINE INJECTION Specification

Pacakaging (Quantity Per Box)
1 Vial per box

Indication
Treatment of Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML)

Salt Composition
Decitabine

Origin of Medicine
India

Dosage Form
Lyophilized Powder for Injection

Drug Type
Generic

Ingredients
Decitabine

Physical Form
Tablets

Function
Anticancer medication, hypomethylating agent

Recommended For
Cancer Treatment

Dosage
As directed by physician

Dosage Guidelines
Follow physicians prescription

Suitable For
Adults

Quantity
1 Vial

Storage Instructions
Store below 25C, protect from light

Reconstitution
Reconstitute with sterile water for injection before administration

Pack Type
Single use vial

Prescription/Nonprescription
Prescription

Marketed In
Hospitals, oncology clinics

Product Type
Anti-neoplastic agent

Strength
50 mg per vial

Brand Name
DECZUBA

Administration Route
Intravenous (IV)

Mechanism of Action
Inhibits DNA methyltransferase, leading to cell differentiation or death

Shelf Life
24 months

ATC Code
L01BC08

Formulation
Lyophilized powder

DECZUBA DECITABINE INJECTION Trade Information

Minimum Order Quantity
1 Bottle

Packaging Details
PACK OF 1 VIAL

Main Domestic Market
All India

Certifications
brand name - deczuba content- decitanibe form- injection stregth- 50 mg manufacturer by - glenmark packing - pack of 1 vial

About DECZUBA DECITABINE INJECTION

PRODUCT DETAILS

BRAND NAME: DECZUBA.

CONTENT: DECITABINE.

STRENGTH: 50MG.

PACKAGING: PACK OF 1 VIAL.

MANUFACTURED BY: GLENMARK.

Note: -DECZUBAIs APrescription Drug And Should Be Used Under Proper Medical Guidance And Advice.Do Not Share The Medicine With Others, Since They May Be Suffering From AProblem That Is Not Effectively Treated By This Drug..............

How DECZUBA Works

DECZUBA functions as a hypomethylating agent by inhibiting DNA methyltransferase. This leads to the reactivation of silenced genes, causing abnormal cancer cells to differentiate or undergo cell death, making it an effective treatment for certain blood-related cancers.

Safe and Effective Administration

DECZUBA is administered intravenously following reconstitution with sterile water for injection. The dosage and administration schedule are determined by a physician and are tailored to the patients specific medical requirements. Always ensure a trained healthcare professional prepares and administers the injection.

Designed for Clinical Use

DECZUBA is offered in single-use vials and is available primarily in hospitals and oncology clinics. Its formulation as a lyophilized powder ensures stability and easy transport, while strict prescription-only distribution ensures safe, monitored usage.

FAQs of DECZUBA DECITABINE INJECTION:

Q: How should DECZUBA Decitabine Injection be administered?

A: DECZUBA should be reconstituted with sterile water for injection by a healthcare professional before being administered intravenously. It is important that only trained medical staff perform the preparation and infusion.

Q: What conditions is DECZUBA recommended for?

A: DECZUBA is indicated for the treatment of adults with Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML), as directed by a physician.

Q: When should I take DECZUBA?

A: DECZUBA is given according to a dosage regimen prescribed by your oncologist. The frequency and timing depend on your diagnosis, clinical response, and individual treatment plan.

Q: Where is DECZUBA typically administered?

A: DECZUBA is usually administered in a controlled clinical setting such as a hospital or oncology clinic, where medical staff can monitor the infusion and any potential side effects.

Q: What is the process for preparing DECZUBA for injection?

A: The vial should be reconstituted with sterile water for injection immediately before use. The solution should then be administered intravenously according to the physicians instructions. Discard any unused portion after a single use.

Q: What are the benefits of using DECZUBA for cancer treatment?

A: DECZUBA offers potential clinical benefits by targeting and modifying cancer cell DNA, disrupting their growth, and facilitating the death or normalization of abnormal cells, particularly for patients with MDS and AML.

Q: How should DECZUBA be stored?

A: DECZUBA should be stored below 25C, protected from light, and kept in its original packaging until use to maintain stability and effectiveness. Always follow the storage instructions provided.

Tell us about your requirement